Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 36: 1784-1788, 1990;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gulbis, B.
Right arrow Articles by Ooms, H. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gulbis, B.
Right arrow Articles by Ooms, H. A.

Clinical Chemistry, Vol 36, 1784-1788, Copyright © 1990 by American Association for Clinical Chemistry

Mass concentration of creatine kinase MB isoenzyme and lactate dehydrogenase isoenzyme 1 in diagnosis of perioperative myocardial infarction after coronary bypass surgery

B Gulbis, P Unger, A Lenaers, JM Desment and HA Ooms
Department of Clinical Chemistry, Hopital Erasme-ULB, Brussels, Belgium.

Recent advances in methodology allow the mass concentration of creatine kinase MB isoenzyme (CK-MB), and of lactate dehydrogenase isoenzyme 1 (LD1) to be determined quickly and easily as routine, emergency tests. We evaluated these tests as diagnostic criteria of perioperative myocardial infarction (PMI) after coronary bypass surgery. These tests were compared with the usual measurements of CK-MB activity by immunoinhibition and LD1 by electrophoresis and with other biological markers of myocardial infarction such as total CK, total LD, and aspartate aminotransferase. Sixty-one patients who underwent coronary bypass grafting were followed pre- and postoperatively by enzyme determinations and electrocardiography; a subgroup was monitored by myocardial scintigraphy. CK-MB mass appeared to be the best marker of PMI during the first 48 h, although LD1 was the marker of choice from days 2 to 4.


The following articles in journals at HighWire Press have cited this article:


Home page
Ann. Thorac. Surg.Home page
E. Kilger, B. Pichler, F. Weis, A. Goetz, P. Lamm, A. Schutz, D. Muehlbayer, and L. Frey
Markers of myocardial ischemia after minimally invasive and conventional coronary operation
Ann. Thorac. Surg., December 1, 2000; 70(6): 2023 - 2028.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
L. Jacquet, P. Noirhomme, G. El Khoury, M. Goenen, M. Philippe, J. Col, and R. Dion
Cardiac troponin I as an early marker of myocardial damage after coronary bypass surgery
Eur. J. Cardiothorac. Surg., April 1, 1999; 13(4): 378 - 384.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. Menasche, W. R. E. Jamieson, W. Flameng, M. K. Davies, and on behalf of the Multinational Acadesine Study Gro
ACADESINE: A NEW DRUG THAT MAY IMPROVE MYOCARDIAL PROTECTION IN CORONARY ARTERY BYPASS GRAFTINGResults of the first international multicenter study
J. Thorac. Cardiovasc. Surg., October 1, 1995; 110(4): 1096 - 1106.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the American Association for Clinical Chemistry.